Kessler Topaz Meltzer & Check, LLP: Investor Class Action Filed Against Teladoc Health, Inc. for Securities Fraud Violations
Company Name: Teladoc Health, Inc.
Court: United States District Court for the Southern District of New York
Case Number: 18-cv-11603
Judge: The Hon. Gregory Howard Woods III
Class period: between March 3, 2016, and December 5, 2018
Security Type: Securities

Case Background:

On December 12, 2018, the initial complaint in this securities class action was filed against Teladoc Health, Inc. ("Teladoc" or the “Company”), and certain of Teladoc’s directors and officers, asserting violations of sections 10(b) and 20(a) of the Securities Exchange Act. 

The complaint alleged that, throughout the class period, the defendants made materially false and misleading statements regarding the Company’s business, operational and compliance policies. Specifically, the defendants made false and/or misleading statements and/or failed to disclose that: (i) Teladoc's Chief Financial Officer (“CFO”) was engaged in an inappropriate sexual relationship with a subordinate; (ii) the CFO and this subordinate engaged in insider trading to provide themselves with undue benefits; (iii) the CFO caused the subordinate to receive promotions for which she was unqualified, thereby negatively impacting the Company’s operations; (iv) the Company’s enforcement of its own purported employment and trading policies were inadequate to prevent the foregoing conduct; and (v) as a result, the Company’s public statements were materially false and misleading at all relevant times.

This is a federal securities class action on behalf of those who purchased or otherwise acquired Teladoc securities between March 3, 2016, and December 5, 2018, inclusive.

Current Status of Case:

On June 25, 2019, the lead plaintiffs filed a second amended consolidated complaint. On September 13, 2019, the defendants filed a motion to dismiss the second amended consolidated complaint. On November 30, 2020, the Court granted the defendants’ motion to dismiss the action without prejudice and with leave for lead plaintiffs to amend their complaint.

If you wish to discuss this action or have any questions concerning this notice or your rights or interests with respect to these matters, please contact Kessler Topaz Meltzer & Check, LLP: James Maro, Esq. (484-270-1453) or Adrienne Bell, Esq. (484-270-1435); toll-free at (844) 887-9500; or via e-mail at If you would like additional information about the suit, please click on the link "Submit Your Information" above and fill out the form as promptly as possible.

Please complete this form relating to your transactions for Teladoc Health, Inc. (NYSE: TDOC) securities between March 3, 2016, and December 5, 2018, both dates inclusive (the “Class Period”). 

You may also contact James Maro, Esq. (484) 270-1453 or Adrienne Bell, Esq. (484) 270-1435 or toll free at (844) 887-9500, or you may submit your information via email at, or you may click here to print a PDF of this form.

* Denotes required field
# of Shares
Price per Share
Principal Amount
Amount Paid
Series or CUSIP
# of Contracts
Price per Contract
Exercise Price
Expiration Date
Did you purchase shares of Teladoc Health, Inc. (2019) prior to the Class Period?
Are you a current or former employee of Teladoc Health, Inc. (2019)?
The submission of this form does not create an attorney-client relationship, nor an obligation on the part of Kessler Topaz or you to file a lead plaintiff motion in this matter. Any information you submit will be maintained as confidential. If Kessler Topaz, in its sole discretion, believes that you might be an appropriate lead plaintiff candidate, Kessler Topaz will contact you to discuss the matter and whether to establish an attorney client relationship. By signing this form you are authorizing us to contact you regarding this case and/or future cases.
I agree to the KTMC
I would like to receive
new case alerts by email